Description
This chapter offers a comprehensive analysis of the economic factors influencing the HPV vaccine across its lifecycle. It examines critical phases, including research and development, pricing and market dynamics, marketing strategies, supply chain management, and post-market economic impacts on consumers and healthcare providers. By exploring these interconnected stages, the chapter aims to display the economic viability of the HPV vaccine market and its potential long-term benefits. Additionally, the chapter discusses future research directions, particularly in relation to the evolving regulatory landscape and the implications of emerging vaccine technologies.
Details
Title
- ForkHPV: The Business and Economics of the HPV Vaccine
Contributors
- Ger, Benjamin (Author)
- Peterson, Kylie (Co-author)
- Viton, Rosalia (Co-author)
- Salter, Martha (Co-author)
- Kizer, Aidan (Co-author)
- Compton, Carolyn (Thesis director)
- Xie, Man (Committee member)
- Iqbal, Aneel (Committee member)
- Larson, David (Committee member)
- Barrett, The Honors College (Contributor)
- Dean, W.P. Carey School of Business (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2024-12
Resource Type
Collections this item is in